Thyroid hormones may hold clues to kidney disease progression

NCT ID NCT07663773

First seen Jun 23, 2026 · Last updated Jun 23, 2026

Summary

This observational study will measure thyroid hormone levels in stored blood and urine samples from 51 people with severe chronic kidney disease (stages 4 and 5). Researchers aim to understand how these hormones differ in patients with and without polycystic kidney disease. The study does not involve any new treatment or intervention.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGES 4 AND 5) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinical Research Centre for Rare Diseases Aldo e Cele Daccò

    Ranica, BG, 24020, Italy

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could reveal how thyroid hormones relate to kidney disease severity, potentially guiding future treatments.

What could go wrong

This is an observational study using stored samples, so it cannot prove cause and effect. Results may not apply to all kidney disease patients.

Conditions

The condition(s) this trial relates to.

Renal Insufficiency, Chronic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.